These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26136289)

  • 1. Rotational Atherectomy Combined With Bioresorbable Vascular Scaffold Implantation: A Feasible Approach for Recurrent In-stent Restenosis When Other Therapies Failed.
    Pereira-da-Silva T; Patrício L; Cruz Ferreira R
    J Invasive Cardiol; 2015 Jul; 27(7):E143-5. PubMed ID: 26136289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience.
    Moscarella E; Varricchio A; Stabile E; Latib A; Ielasi A; Tespili M; Cortese B; Calabrò P; Granata F; Panoulas VF; Franzone A; Trimarco B; Bonzani G; Esposito G; Colombo A
    Int J Cardiol; 2015 Nov; 199():366-72. PubMed ID: 26241643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis of Coronary Bioresorbable Vascular Scaffolds.
    Alfonso F; García-Guimaraes M
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold (BVS) Implantation in Patients With Chronic Total Coronary Occlusions: Acute Procedural and Short-Term Clinical Results.
    Goktekin O; Yamac AH; Latib A; Tastan A; Panoulas VF; Sato K; Erdogan E; Uyarel H; Shah I; Colombo A
    J Invasive Cardiol; 2015 Oct; 27(10):461-6. PubMed ID: 26429848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries.
    Lane JP; Perkins LE; Sheehy AJ; Pacheco EJ; Frie MP; Lambert BJ; Rapoza RJ; Virmani R
    JACC Cardiovasc Interv; 2014 Jun; 7(6):688-95. PubMed ID: 24835327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Malapposition After Bare-Metal Stent, But Not Bioresorbable Scaffold: Insights on Intraindividual Heterogeneity in Plaque and Device Response.
    Cortese B; Buccheri D; Silva Orrego P; Biondi-Zoccai G
    J Invasive Cardiol; 2015 Aug; 27(8):E171-2. PubMed ID: 26232021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of In-Stent Restenosis Using Excimer Laser Coronary Atherectomy and Bioresorbable Vascular Scaffold Guided by Optical Coherence Tomography.
    Pereira GTR; Dallan LAP; Vergara-Martel A; Alaiti MA; Bezerra HG
    Cardiovasc Revasc Med; 2021 Jan; 22():44-49. PubMed ID: 32448779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial.
    Nakatani S; Onuma Y; Ishibashi Y; Muramatsu T; Iqbal J; Zhang YJ; van Geuns RJ; Ormiston JA; Serruys PW
    EuroIntervention; 2015 Mar; 10(11):1288-98. PubMed ID: 24572936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
    Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioresorbable vascular scaffold to treat in-stent restenosis: Single-center experience.
    Picard F; Avram R; Marquis-Gravel G; Tadros VX; Ly HQ; de Hemptinne Q; Dorval JF; L'allier PL; Tanguay JF
    J Interv Cardiol; 2017 Dec; 30(6):558-563. PubMed ID: 28786151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.
    Muramatsu T; Onuma Y; García-García HM; Farooq V; Bourantas CV; Morel MA; Li X; Veldhof S; Bartorelli A; Whitbourn R; Abizaid A; Serruys PW;
    JACC Cardiovasc Interv; 2013 Mar; 6(3):247-57. PubMed ID: 23517836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.
    Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F
    Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcified in-stent restenosis: a rare cause of dilation failure requiring rotational atherectomy.
    Alfonso F; Sandoval J; Nolte C
    Circ Cardiovasc Interv; 2012 Feb; 5(1):e1-2. PubMed ID: 22338004
    [No Abstract]   [Full Text] [Related]  

  • 20. Positive Vessel Remodeling and Appearance of Pulsatile Wall Motion at Long-Term Follow-Up After Bioresorbable Scaffold Implantation in a Chronic Total Occlusion.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1635-7. PubMed ID: 26386767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.